Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Skin problems are very common in people with end-stage kidney disease.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Melatonin may reduce skin damage caused by X-rays in rats.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Epigenetic factors play a crucial role in skin health and disease.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

New research suggests treating hair loss should focus on common inflammation rather than individual molecules.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Cornification is how skin cells die to form the protective outer layer of skin, hair, and nails.

Topical retinoids effectively improve photodamaged skin.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Iron deficiency anemia can cause itching, which often improves with iron supplements.

New therapies are being developed that target integrin pathways to treat various diseases.